FORESTIERI, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 510
EU - Europa 445
AS - Asia 73
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.041
Nazione #
US - Stati Uniti d'America 504
IT - Italia 273
DE - Germania 52
NL - Olanda 50
CN - Cina 43
FR - Francia 23
VN - Vietnam 18
FI - Finlandia 14
IE - Irlanda 14
IN - India 12
CI - Costa d'Avorio 11
CA - Canada 5
GB - Regno Unito 5
UA - Ucraina 5
SE - Svezia 4
EU - Europa 2
BG - Bulgaria 1
BZ - Belize 1
DK - Danimarca 1
RS - Serbia 1
RU - Federazione Russa 1
SI - Slovenia 1
Totale 1.041
Città #
Chandler 130
Amsterdam 50
Napoli 39
Ashburn 28
Millbury 28
Princeton 19
Naples 18
Dong Ket 16
Des Moines 14
Beijing 13
Nanjing 12
Pune 9
Milan 8
Boston 7
Jacksonville 7
Casoria 6
Lawrence 6
Rozzano 6
Wilmington 6
Redwood City 5
Rome 5
Seattle 5
Dearborn 4
Menfi 4
Ottawa 4
Pomigliano d'Arco 4
Ann Arbor 3
Formia 3
Hebei 3
Jiaxing 3
Nanchang 3
Serravalle Scrivia 3
Washington 3
Castellammare Di Stabia 2
Changsha 2
Duncan 2
Fairfield 2
Genova 2
Hanoi 2
Latina 2
Luco dei Marsi 2
Mariano Comense 2
Montauro 2
Nola 2
Orange 2
Paris 2
Piove Di Sacco 2
Salerno 2
Sennori 2
Suri 2
Teano 2
Tianjin 2
Villaricca 2
Arzano 1
Augusta 1
Aversa 1
Bari 1
Belize City 1
Benevento 1
Boardman 1
Bozen 1
Caivano 1
Capena 1
Casalnuovo 1
Caserta 1
Castelli Calepio 1
Catania 1
Cesenatico 1
Chicago 1
Deiva Marina 1
Edinburgh 1
Falkenstein 1
Falls Church 1
Forlì 1
Frattamaggiore 1
Fuzhou 1
Giugliano in Campania 1
Gragnano 1
Hangzhou 1
Houston 1
Kunming 1
Lanuvio 1
Lauro 1
Leawood 1
Mezzolombardo 1
Mirabella Eclano 1
Mori 1
Mountain View 1
Mugnano Di Napoli 1
New Delhi 1
Nocera Inferiore 1
Norwalk 1
Novi Sad 1
Nutley 1
Ottaviano 1
Palagonia 1
Palma Campania 1
Pomigliano D'arco 1
Pozzuoli 1
Rimini 1
Totale 561
Nome #
null 223
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy 82
Long-term disease control with lapatinib and capecitabine in a patient with HER2-positive metastatic breast cancer pretreated with trastuzumab and trastuzumab-emtansine 69
Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study 43
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: An open-label, 2 × 2 factorial, randomised phase 3 trial 42
Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab. 41
It is no longer the time to disregard thyroid metastases from breast cancer: A case report and review of the literature 39
Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era 39
Long-term survival and BRCA status in male breast cancer: A retrospective single-center analysis 38
Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women 38
Combined effect of obesity and diabetes on early breast cancer outcome: A prospective observational study 36
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial 36
Tumor characteristics and prognosis in familial breast cancer 34
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI) 34
Case Report: Detection of a Novel Germline PALB2 Deletion in a Young Woman With Hereditary Breast Cancer: When the Patient's Phenotype History Doesn't Lie 31
Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series 29
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study 29
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials 27
Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer 25
Hepatocellular carcinoma (HCC): Results of a multimodal approach 25
Management of primary Non-Hodgkin's lymphoma (PNHL) of the liver: Our experience 25
Necrotic solitary nodule of the liver: Case reports and pathogenetic hypothesis 23
Capitolo 15: i Tumori Ginecologici 23
Core curriculum. Oncologia clinica 18
Phase II study of raltitrexed (Tomudex) as second-line treatment in advanced colorectal cancer (ACC) 16
Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054] 15
Phase II trial of gemcitabine plus carboplatin for urothelial transitional cell carcinoma (UTCC) in advanced or metastatic stage 12
Primary non-Hodgkin's lymphoma of the liver: Case report 11
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial 7
Totale 1.110
Categoria #
all - tutte 3.660
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.660


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201922 0 0 0 0 0 0 0 0 0 11 6 5
2019/2020114 32 5 7 4 8 8 5 3 4 12 16 10
2020/2021127 4 4 10 5 19 8 13 8 27 2 9 18
2021/2022175 7 1 5 0 0 5 4 4 14 21 56 58
2022/2023312 27 30 9 28 36 30 9 28 43 54 13 5
2023/2024119 5 28 18 11 5 27 2 20 3 0 0 0
Totale 1.110